Abnormal platelet procoagulant activity
Abnormal platelet procoagulant activity, also known as Scott syndrome, is characterized by a simple defect in platelet procoagulant activity. This disease is inherited in an autosomal recessive manner, and its etiology and pathogenesis have not yet been elucidated.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Adults, women, people who often have toothache -
Related symptoms:
Heavy menstrual flow Bleeding after tooth extraction Hematoma formation Bone marrow megakaryocyte maturation disorder Abnormal blood picture -
Concurrent disease:
Related Drugs
Recombinant Human Coagulation Factor VIIa for Injection
Indication: It is used for the following patient groups to treat bleeding episodes and prevent bleeding during surgical procedures or invasive procedures. 1. Congenital hemophilia patients with inhibitors of coagulation factor VIII or IX > 5BU; 2. Congenital hemophilia patients who are expected to have a high memory response to injection of coagulation factor VIII or coagulation factor IX; 3. Acquired hemophilia patients; 4. Congenital FVII deficiency patients; 5. Thrombasthenia patients with GPⅡb-Ⅲa and/or HLA antibodies and who have been or are currently ineffective or poorly responsive to platelet transfusions.